Safety, specifically

The Interaction Nobody Prints On The Front Of The Bottle

Four of the nine ingredients here have specific, documented reasons to check before starting. Two share a pathway with three classes of prescription medicine; two have published files of liver reports. None of that is on the label, and a page that tells everyone to ask about everything has told nobody anything.

By Jelly Force Team · Last updated September 21, 2026 · 9 min read · Safety, specifically · Reviewed by Dr. Lindsay Ogle

Why a general warning is useless

Every supplement website carries a line telling the reader to consult a healthcare professional before use. Most carry it several times, and some carry it on every section of every page.

The trouble with a warning that applies to everything is that it distinguishes nothing. A reader taking nothing at all and a reader on a daily nitrate get the same sentence, which means the second reader gets no signal. And a page that keeps telling you to ask a doctor quietly implies the product does something that needs supervising, which is its own kind of claim.

Being specific works better. Four ingredients here have specific documented reasons to check, and below is who should check, why, and what to say.

The arginine and horny goat weed pathway, and the three classes of medicine it meets

L-arginine is the seventh name on the panel and its one amino acid. It is the amino acid the body converts into nitric oxide, and nitric oxide relaxes the smooth muscle in a blood vessel wall. That is why it is in a male-vitality product: vessel relaxation is the physical event the whole category is about.

It is also why it interacts. Three classes of prescription medicine act on the same physiology, and their effects are additive rather than alternative.

• Nitrates. Isosorbide, glyceryl trinitrate and the rest release nitric oxide directly. This is the same pathway one step earlier, and it includes the spray or tablet somebody uses only occasionally for angina.
• Blood-pressure medicines. Most either widen vessels or reduce the volume moving through them. Arginine alone lowers pressure measurably: eleven randomised trials in 387 people found a 5.4 mmHg systolic and 2.7 mmHg diastolic fall at 4 to 24 grams a day.
• Erectile dysfunction drugs. Sildenafil, tadalafil and the rest block PDE5, the enzyme that breaks down nitric oxide's second messenger. Same pathway, further along, and their own drug information warns about nitrates.
• Horny goat weed. The last name on the panel, and one the seller's list leaves out. Its compound icariin inhibits PDE5 in the test tube, though about eighty times more weakly than sildenafil in one assay. Nobody has measured an interaction in people; the mechanism is the reason to mention it.
• What stacking feels like. Light-headedness on standing, most often. That is the symptom to notice rather than anything dramatic.

The trial doses matter here as everywhere else. The erectile meta-analysis pooled ten trials at 1,500 to 5,000 mg a day, and the blood-pressure work used grams. A Jelly Force gummy delivers an 82 mg blend across nine names, with arginine printed after the 5 mg of caffeine, so the arginine in it is a small fraction of any of those numbers.

Which cuts both ways, and both ways are worth saying. It makes a clinically significant interaction much less likely at this scale. It does not make the conversation unnecessary, because the person who needs it is on a medicine whose whole purpose is to act on that pathway, and they are entitled to decide with the information rather than without it.

The ashwagandha and tribulus file

Ashwagandha is the sixth name on the panel and one of the best-evidenced. It also has the largest published adverse-event file on the bottle, and that file has grown rather than shrunk.

A 2026 scoping review gathered thirteen publications describing twenty-five patients whose liver injury was attributed to ashwagandha. Three features recur across them. It took weeks of use rather than days to appear. The bloodwork pattern was bile-duct rather than liver-cell in most of the series, which is why jaundice and itching were the usual presenting complaints. And recovery followed stopping, over weeks to months, in every patient but one, who needed a transplant. The LiverTox monograph records the same signal.

Separately, a case report describes thyroid over-activity presenting with a fast heart rhythm in a patient taking ashwagandha, and it is not the only report of its kind. The proposed mechanism is that ashwagandha raises thyroid hormone levels, which matters most to somebody whose levels are already being managed with replacement.

Tribulus, eighth on the panel and missing from the advertising, has a shorter file of the same kind: severe liver and kidney injury in a 46-year-old man after two months of daily tribulus supplements, who recovered after treatment.

Only groups with a documented reason are listed. A list that names everybody names nobody.

The rest of the panel, caffeine included

Caffeine is printed at 5 mg a gummy, which is small and is still worth knowing if you avoid it for sleep, anxiety or heart rhythm. Green tea extract has a liver file of its own, but at catechin intakes of 140 mg a day and more, above the weight of this whole blend.

Muira puama, maca and catuaba carry no safety signal in the indexed literature at the amounts a bottle like this holds. That is not the same as having been shown to be safe. It means nobody has looked hard, which is the ordinary position for a traditional-use botanical and is worth saying plainly rather than reading as reassurance.

Maca is the most reassuring of the three for a reason unrelated to trials: it is eaten as a food in Peru, in quantity, and the twelve-week trials at gram doses reported no safety problem. The other two are traded as tonics rather than eaten, and their published record is animal work plus a few uncontrolled studies of multi-herb mixtures, none of which reported a severe reaction.

One line from that animal work belongs on a safety page rather than nowhere: crude catuaba extract impaired fertility in adult female rats in a published study. The product is sold to adult men and the doses have nothing to do with a gummy. It is still a reason this is not a bottle to share.

The risk that is not on the label at all

There is a hazard in this category that no ingredient list can warn you about, and it is the reason a safety article here reads differently from one about a multivitamin.

A worldwide review of adulteration in sexual enhancement supplements describes prescription erectile-dysfunction drugs being added to products sold as herbal, repeatedly, across markets, over years. Analytical screens of products bought over the counter have found synthetic PDE-5 inhibitors in samples whose labels named only plants.

The danger is not the herb. It is an undeclared vasodilator meeting a nitrate in somebody who had no reason to think a drug was involved — exactly the interaction the first half of this article is about, arriving without warning.

Nothing of the kind is alleged about this product, and no measurement of it exists either way. What can be said is what such a product looks like: it works quickly, which nothing on this label has a route to do at the amounts one gummy holds; it is sold by somebody who cannot be telephoned, which this desk can be on +1 (302) 200-3480; and it carries no lot number, which this one does.

What the bottle itself says, and what it leaves out

The wrap carries a Supplement Facts panel, a suggested use of one gummy once daily and a general warning: pregnant or nursing, taking medication or living with a medical condition, consult a doctor first, and stop if anything goes wrong. Keep out of the reach of children. That is the ordinary boilerplate of the category, and it names no ingredient.

The panel does settle two old gummy questions: the gelling agent is apple pectin, not gelatin, and a gummy carries 3 g of added sugar and 10 calories. Three practical gaps remain, and none is unusual.

• Nothing on the bottle mentions blood pressure. Two names on the panel act on the vessel-widening pathway, and the label connects neither to anything.
• Nothing mentions the liver, the kidney or the thyroid. The ashwagandha and tribulus reports are specific, and they have not yet reached the packaging of most products containing either.
• The advertising leaves out the interaction names. Horny goat weed, the ingredient most directly on the prescription tablets' pathway, is on the panel and not in the seller's list, and neither is the caffeine.

None of that is a failure to comply with anything. A supplement label is not required to carry an interaction table and almost none does. It is simply the reason a page like this one has to exist somewhere, and the reason it is on the website selling the bottle rather than only on somebody else's.

The two sentences worth saying to a prescriber

The conversation is short and the specificity is what makes it useful. Two sentences cover all four documented cautions on this label.

1. On the pathway: “I am thinking of taking a supplement containing L-arginine and horny goat weed. I am on [the nitrate, the blood-pressure medicine, the ED prescription]. Does that change anything?”
2. On the liver, kidney and thyroid: “It also contains ashwagandha and tribulus, which have case reports of liver injury, and ashwagandha has thyroid reports too. I have [liver disease, kidney disease, thyroid disease, thyroid replacement]. Is that a reason not to?”

The side effects page sets the same material out in more detail, and the suitability page lists the four groups this bottle does not suit.

References